Copyright
©The Author(s) 2017.
World J Gastroenterol. May 7, 2017; 23(17): 3174-3183
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3174
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3174
Table 2 Histology (hematoxylin and eosin staining) of the distal squamous epithelium, proximal Barrett’s esophagus and distal Barrett’s esophagus at baseline and after successful acid reflux suppression with increasing doses of proton pump inhibitor in non-operated patients (group 1) and anti-reflux operated Barrett’s esophagus patients (group 2), with and without normal acid reflux
Variable | Group 1, baseline(n = 23) | Group 1, no reflux(n = 23) | P value | Group 2, reflux(n = 14) | Group 2, no reflux(n = 16) | P value |
Squamous epithelium | ||||||
Dilated intercellular space (%) | 87.0 | 73.9 | < 0.05 | 78.6 | 68.8 | 0.50 |
Basal cell thickness (% score 0/1/2) | 4.3/82.7/13.0 | 21.7/69.6/8.7 | 0.22 | 50.0/50.0/0 | 12.5/87.5/0 | < 0.05 |
Papillary length (% score 0/1/2) | 0/34.8/65.2 | 8.7/52.2/39.1 | < 0.05 | 7.1/42.9/50.0 | 18.8/43.7/37.5 | 0.53 |
Epithelial neutrophils and eosinophils (% score 0/1/2) | 39.2/30.4/30.4 | 47.8/26.1/26.1 | 0.86 | 35.7/50.0/14.3 | 62.5/25/12.5 | 0.27 |
Epithelial mononuclear cells (% score 0/1/2) | 60.9/39.1/0 | 87.0/13.0/0 | 0.09 | 57.1/42.9/0 | 56.3/43.7/0 | 0.47 |
Proximal BE | ||||||
Epithelial neutrophils and eosinophils (% score 0/1/2) | 43.5/30.4/26.1 | 47.8/30.4/21.7 | 0.06 | 42.9/21.4/35.7 | 81.3/6.2/12.5 | < 0.05 |
Epithelial mononuclear cells (% score 0/1/2) | 91.3/8.7/0 | 95.7/4.3/0 | 0.26 | 92.9/7.1/0 | 93.7/6.3/0 | 0.24 |
Distal BE | ||||||
Epithelial neutrophils and eosinophils (% score 0/1/2) | 78.3/8.7/13.0 | 82.6/13/4.4 | 0.74 | 85.7/0/14.3 | 43.8/50/6.2 | < 0.05 |
Epithelial mononuclear cells (% score 0/1/2) | 73.9/13.0/13.0 | 56.5/39.1/4.4 | 0.10 | 92.9/7.1/0 | 100/0/0 | 0.09 |
- Citation: Baldaque-Silva F, Vieth M, Debel M, Håkanson B, Thorell A, Lunet N, Song H, Mascarenhas-Saraiva M, Pereira G, Lundell L, Marschall HU. Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett’s esophagus. World J Gastroenterol 2017; 23(17): 3174-3183
- URL: https://www.wjgnet.com/1007-9327/full/v23/i17/3174.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i17.3174